Cargando…

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer

PURPOSE: Increasing evidence suggests that lysyl oxidase-like 2 (LOXL2) contributes to tumor progression. However, the role of LOXL2 in cervical cancer still remains unclear. PATIENTS AND METHODS: We used the TCGA database to analyze the expression of LOXL2 in cervical cancer and its role on surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Jing, Sun, He-Xi, Li, Ying-Chun, Jiang, Li, Zhang, Shan-Ling, Hao, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826188/ https://www.ncbi.nlm.nih.gov/pubmed/31802904 http://dx.doi.org/10.2147/OTT.S217794

Ejemplares similares

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
por: Cuevas, Eva P., et al.
Publicado: (2014)

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
por: Park, Pil-Gu, et al.
Publicado: (2017)

Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression
por: Ahn, Sung Yong, et al.
Publicado: (2021)

Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinoma
por: Saito, Yuki, et al.
Publicado: (2020)

LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway
por: Cuevas, Eva P., et al.
Publicado: (2017)

LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype
por: Cao, Canhui, et al.
Publicado: (2020)

HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
por: Huan, Hong-bo, et al.
Publicado: (2017)

A Theoretical Approach to Coupling the Epithelial-Mesenchymal Transition (EMT) to Extracellular Matrix (ECM) Stiffness via LOXL2
por: Deng, Youyuan, et al.
Publicado: (2021)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes
por: He, Dan, et al.
Publicado: (2020)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells
por: Nguyen, Linh Thi Thao, et al.
Publicado: (2016)

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
por: Li, Linna, et al.
Publicado: (2014)

HIV gp120/Tat protein-induced epithelial–mesenchymal transition promotes the progression of cervical lesions
por: Wang, Peizhi, et al.
Publicado: (2023)

TCTP promotes epithelial–mesenchymal transition in lung adenocarcinoma
por: Sun, Ruilin, et al.
Publicado: (2019)

HER4 promotes the progression of colorectal cancer by promoting epithelial-mesenchymal transition
por: Jia, Xiaojing, et al.
Publicado: (2020)

LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
por: Hu, Lin, et al.
Publicado: (2020)

Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression
por: Wang, Yuhui, et al.
Publicado: (2016)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
por: Kong, Jienan, et al.
Publicado: (2016)

Metadherin Promotes Malignant Phenotypes And Induces Beta-Catenin Nuclear Translocation And Epithelial–Mesenchymal Transition In Gastric Cancer
por: Feng, Di, et al.
Publicado: (2019)

ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3
por: Yu, Ting-ting, et al.
Publicado: (2021)

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
por: Vázquez-Naharro, Alberto, et al.
Publicado: (2022)

Mixed lineage kinase ZAK promotes epithelial–mesenchymal transition in cancer progression
por: Li, Linna, et al.
Publicado: (2018)

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
por: Chen, Jia, et al.
Publicado: (2014)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)

Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma
por: Kim, Im-kyung, et al.
Publicado: (2019)

Retraction Note: Baicalein Inhibits Epithelial to Mesenchymal Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells
por: Nguyen, Linh Thi Thao, et al.
Publicado: (2019)

CD36 promotes the epithelial–mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β
por: Deng, Min, et al.
Publicado: (2019)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

Periostin promotes malignant potential by induction of epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma
por: Mino, Masaaki, et al.
Publicado: (2017)

S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial–mesenchymal transition
por: Tian, Tian, et al.
Publicado: (2017)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism
por: Vitaliti, Alessandra, et al.
Publicado: (2022)

P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition
por: Cao, Yuan, et al.
Publicado: (2020)

Emerging roles of epithelial-mesenchymal transition in hematological malignancies
por: Chen, San-Chi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_41v63c71f3k08j0r681vrt0mfm